ConductScience.org, home

Paper4880296

The generic inequivalence of drugs.

Varley AB. JAMA, 1968. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. The generic inequivalence of drugs. Papers, record 4880296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4880296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The generic inequivalence of drugs.
PubMed
Journal
JAMA
PubMed
Year
1968
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
51
iCite
Revised in PubMed
2016-10-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Varley ABA B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TolbutamideMajor topic
Analysis of Variance
Clinical Trials as Topic
Drug Compounding
Humans
Hypoglycemia
Pharmaceutic Aids
Solubility

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
37525781Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline.Cureus2023https://conductscience.org/library/papers/37525781PubMed
22454936Bioavailability of different preparations of paracetamol.Br J Clin Pharmacol1974https://conductscience.org/library/papers/22454936PubMed
5761892What's in a pill?Br Med J1969https://conductscience.org/library/papers/5761892PubMed
4854667The bioavailability in man of marketed brands of chlorpropamide.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4854667PubMed
4851052Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4851052PubMed
4605123Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.Ir J Med Sci1974https://conductscience.org/library/papers/4605123PubMed
973984Serum concentrations and bioavailability of rifampicin and isoniazid in combination.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973984PubMed
15845Plasma concentrations, bioavailability and dissolution of chlorpropamide.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/15845PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4880296

GET https://conductscience.org/api/papers/v1/4880296/authors